A phase 1, first-time-in-human study of MEDI9197, a TLR7/8 agonist, administered intratumorally in subjects with a solid tumor cancer.
2016
TPS3095Background: Toll-like receptors (TLRs) are proteins in the innate immune system that, once bound to their ligands, directly activate innate immune cells, including myeloid dendritic cells, p...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI